Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • NEUROCRINE BIOSCIENCES INC Financial Overview

  • Income Statement: NBIX

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 3.98 M 1.22 M 2.75 M 69.21%
    Gross Profit -3.64 M -8.18 M 4.54 M -125.03%
    Net Income Before Extra Items/Preferred Div -88.61 M -207.30 M 118.69 M -133.94%
    Operating Income -69.46 M -111.34 M 41.89 M -60.31%
  • Cash Flow: NBIX

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing -1.45 M 57.18 M -58.63 M 4,038.09%
    Net Cash Flow - Investing -44.43 M -20.84 M -23.59 M 53.10%
    Net Cash Flow/Operating Activities -74.17 M -59.33 M -14.84 M 20.01%
  • Balance Sheet: NBIX

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 118.18 M 276.65 M -158.47 M -134.09%
    Total Liabilities 81.41 M 157.96 M -76.55 M -94.03%
    Shareholders Equity 36.77 M 118.70 M -81.92 M -222.77%
  • Key Ratios / Statistics: NBIX

    • Valuation

      Price/Earnings (TTM) -1.39
      Price/Sales (TTM) 30.95
      Price/Book (MRQ) 111.24
      Price/Cash Flow (TTM) -1.95
    • Profitability

      Gross Margin -91.45
      Operating Margin -1,747.32
      Profit Margin -2,229.26
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 3.09
      Current Ratio (MRQ) 2.42
      Long Term Debt-to-Equity (MRQ) 0.00
    • Management Effectiveness

      Return on Equity (TTM) -113.47
      Return on Assets (TTM) -50.00
      Return on Investments (TTM) -63.26